Diffuse cutaneous bullous mastocytosis with IgM deposits at dermo-epidermal junction

2015 ◽  
Vol 43 (3) ◽  
pp. 263-269 ◽  
Author(s):  
Kinga Cristina Slavescu ◽  
Roxana Chiorean ◽  
Sorina Danescu ◽  
Madalina Bota ◽  
Liliana Rogojan ◽  
...  

1970 ◽  
Vol 101 (5) ◽  
pp. 547-564 ◽  
Author(s):  
M. Orkin
Keyword(s):  


2014 ◽  
Vol 53 (6) ◽  
pp. 761-763 ◽  
Author(s):  
Rajesh Verma ◽  
Biju Vasudevan ◽  
Pragasam Vijendran ◽  
Debdeep Mitra


1981 ◽  
Vol 76 (2) ◽  
pp. 181-188 ◽  
Author(s):  
Ageu Godoy Magalhães Filho ◽  
Antônio Victoriano Barbosa ◽  
Teresa Cristina Ferreira

Twenty one cases of hepatoesplenic schistosomiasis patients without clinical and laboratory evidence of renal disease, were studied by surgical biopsies using light microscopy and immunofluorescence. The cases were classified histologically as: normal pattern (6 cases); minimal changes (6 cases); and mesangial proliferative glomerulonephritis (9 cases). By the immunofluorescence microscopy using anti IgM, IgG, IgA and C3, the predominant finding in all biopsies, except the normal cases, was granular deposits of IgM in the mesangium along with C3. On the other hand, IgG was present in all cases including normal biopsies along the capillary walls. However IgG was also present in the mesangium only in cases with glomerular lesions. This finding may well be similar to that recently described as IgM mesangial nephropathy. According to our cases a mesangial proliferative glomerulonephritis, characterized by segmental cell proliferation and deposition of IgM in the mesangium, is probably the entity found in the early stages of mansonic schistosomiasis.



Author(s):  
K. S. Komissarov ◽  
M. V. Dmitrieva ◽  
T. A. Letkovskaya ◽  
V. S. Pilotovich ◽  
O. V. Krasko

The aim of the study was to evaluate relations between the deposition of IgA, IgG, IgM, C3, C1q and baseline clinical features and pathological findings.According to exclusion criteria, 72 patients with diagnosed primary IgAN who were biopsied from 2015 to 2017 in the district of the Minsk city, Belarus were included for retrospective analysis. All biopsy had to be reviewed according to the Oxford classification (MEST-C). We examined the immunofluorescence staining with antibodies against IgG, IgA, IgM, C3, C1q.Mean age was 32 (26; 42.5) years, 72.2% was men, 48.6% of the patients had arterial hypertension. Median of proteinuria was 870 (355; 1420) mg/day, 8.4% of the patients had isolated hematuria, serum creatinine – 104 (89; 126.5) µmol/l.The patients with 3+ IgA deposits showed a significantly higher percentage of crescents (C1-2) than those with 2+ IgA deposits (p = 0.028). The presence of C3 deposits showed a gradual increase in the percentage of endothelial proliferation (E1) (p = 0.007). The degree of IgA deposits showed a significant negative relation to the IgM deposits (p = 0.01) and a positive relation to the C3 deposits (p = 0.001).We found that the intensity of IgA and C3 deposits is associated with histopathology markers of the acute reaction (C1-2 and E1) according to the Oxford classification. At the same time, the appearance of the IgM deposits testifies the acute phase of the disease as well as the advanced sclerotic stage in some patients.



2019 ◽  
Vol 9 (1) ◽  
pp. 48-54 ◽  
Author(s):  
Taisuke Irifuku ◽  
Ayaka Satoh ◽  
Hiroki Tani ◽  
Kouichi Mandai ◽  
Takao Masaki

Abstract Nivolumab is an anti-programmed cell death-1 antibody that is utilized as an immune checkpoint inhibitor for several malignancies. However, this agent is associated with immune-related adverse events (irAEs), mainly in the spectrum of autoimmune disease including interstitial pneumonia, colitis, type 1 diabetes, and renal impairment. We herein present the case of a 59-year-old man with renal cell carcinoma who developed worsening renal function approximately 4 months after initiation of nivolumab. Urinalysis showed proteinuria and microscopic hematuria along with increase levels of N-acetyl-β-d-glucosaminidase. Renal biopsy revealed acute tubulointerstitial nephritis and thickening of the glomerular basement membranes. Immunofluorescence showed granular IgM deposits in capillary loops. We initiated high-dose prednisolone therapy with nivolumab, which improved renal function and achieved complete remission of proteinuria. Although renal irAEs are considered to be rare and glomerulonephropathy is not typical presentation, physicians need the close monitoring of renal function and urinalysis in patients under immunotherapy with this agents. In addition, our case provides a possible link between nivolumab and immune-mediated glomerulonephropathy.



Author(s):  
N MARTINOVIC ◽  
S VESIC ◽  
K MARTINOVIC
Keyword(s):  


2011 ◽  
Vol 109 (8) ◽  
pp. 830-840 ◽  
Author(s):  
Tin Kyaw ◽  
Christopher Tay ◽  
Surendran Krishnamurthi ◽  
Peter Kanellakis ◽  
Alex Agrotis ◽  
...  






Sign in / Sign up

Export Citation Format

Share Document